After spending time in academia and exploring the unknown, the industry often seems too limited scientifically to those finishing a PhD. We will explore the bridge between the industry and academia to understand how basic scientific findings take shape into products and strategies. We will also follow the career paths of researchers who are in academia or outside of it, professionals that made their choice, followed it through and come to us to tell all about it.
Academia or not? And if not, what else? That is a tough nut to crack. Call us the nutcrackers.
Jan. 25, 2023
Dr. Evan Bai is computational genomic team leader at Vertex Pharmaceuticals. There he leads collaborations across Research, Clinical, and Commercial. By designing and analyzing genomic studies across the drug discovery pipel…
Nov. 17, 2022
Dr. Yaniv Erlich is the co-founder and CEO of Eleven Therapeutics. Prior, he was the CSO of MyHeritage, a consumer genomics company (acquired by Francisco Partners), an Associate Professor of Computer Science at Columbia Uni…
Oct. 11, 2022
Gali Arad and Eran Seger from Protai had talked to us about moving from their previous life in tech and academia into the fast pace of illuminating the druggable Proteome for better cures. Eran Seger is the Co-Founder and CE…
Sept. 1, 2022
Dov Moran, Managing Partner of Grove Ventures, is one of the most prominent Israeli hi-tech leaders in the world. Dov is an investor, inventor, and entrepreneur, who is best known as the inventor of the USB flash drive. He f…
Aug. 1, 2022
Over two years have past since we started this podcast. We learned a lot! We also applied some key take home messages to our own lives and careers. Today we share our progress with you! --- Send in a voice message: https:/…
June 8, 2022
Corrie Painter is the Deputy Director of Count Me In and is a research scientist at the Broad Institute of MIT and Harvard. A trained cancer researcher with a Ph.D. in biochemistry, she completed her postdoctoral work in ca…